|
JP2001523254A
(ja)
|
1997-04-30 |
2001-11-20 |
イーライ・リリー・アンド・カンパニー |
抗血栓剤
|
|
ATE253359T1
(de)
|
1997-05-01 |
2003-11-15 |
Lilly Co Eli |
Antithrombotische mittel
|
|
UA68365C2
(en)
*
|
1997-11-06 |
2004-08-16 |
Wyeth Corp |
Peroral contraception by combination of anti-estrogen and progestin
|
|
US6069153A
(en)
*
|
1998-05-12 |
2000-05-30 |
American Home Products Corporation |
Indenoindoles and benzocarbazoles as estrogenic agents
|
|
AU3894399A
(en)
*
|
1998-05-12 |
1999-11-29 |
American Home Products Corporation |
Benzocarbazole and indenoindole derived estrogenic agents
|
|
US6479535B1
(en)
|
1998-05-15 |
2002-11-12 |
Wyeth |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
|
|
EP1080073A1
(en)
*
|
1998-05-15 |
2001-03-07 |
American Home Products Corporation |
Compositions comprising 2-phenyl-indole compounds and estrogen formulations
|
|
AP1424A
(en)
*
|
1998-05-15 |
2005-06-06 |
Wyeth Corp |
2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
|
|
US7005428B1
(en)
|
1998-06-11 |
2006-02-28 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
|
DE69914563T2
(de)
|
1998-10-30 |
2004-12-16 |
Eli Lilly And Co., Indianapolis |
Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe
|
|
US6380185B1
(en)
|
1999-03-04 |
2002-04-30 |
American Home Products Corporation |
N-substituted benzoyl indoles as estrogenic agents
|
|
CN1342144A
(zh)
*
|
1999-03-04 |
2002-03-27 |
美国家用产品公司 |
用作雌激素药物的n-取代的苯甲酰基吲哚类化合物
|
|
US6358943B1
(en)
|
1999-03-04 |
2002-03-19 |
American Home Products Corporation |
N-substituted indolines as estrogenic agents
|
|
TWI220898B
(en)
*
|
1999-03-04 |
2004-09-11 |
Wyeth Corp |
N-substituted indolines as estrogenic agents
|
|
US6380166B1
(en)
|
1999-09-13 |
2002-04-30 |
American Home Products Corporation |
Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
|
|
BR0013943A
(pt)
*
|
1999-09-13 |
2002-05-14 |
American Home Prod |
Conjugados de glicopiranosìdeos de 2-(4-hidróxi-fenil)-1-[4-(2-amin-1-il-etóxi)-benzil]-1h-indo l-5-óis
|
|
EP1251855A1
(en)
*
|
2000-01-28 |
2002-10-30 |
Endorecherche, Inc. |
Selective estrogen receptor modulators in combination with estrogens
|
|
US20020013327A1
(en)
*
|
2000-04-18 |
2002-01-31 |
Lee Andrew G. |
Compositions and methods for treating female sexual dysfunction
|
|
JP2004502729A
(ja)
*
|
2000-07-06 |
2004-01-29 |
ワイス |
Ssriおよびエストロゲン剤の組み合わせ
|
|
AU2001271784A1
(en)
*
|
2000-07-06 |
2002-01-21 |
Wyeth |
Therapy for prosthesis-related bone degeneration
|
|
AR029538A1
(es)
|
2000-07-06 |
2003-07-02 |
Wyeth Corp |
Composiciones farmaceuticas de agentes estrogenicos
|
|
WO2002003989A2
(en)
*
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted indole compounds for treating sphincter incontinence
|
|
US6509332B2
(en)
|
2000-07-06 |
2003-01-21 |
Wyeth |
Methods of treating excessive intraocular pressure
|
|
EP1656938A1
(en)
|
2000-07-06 |
2006-05-17 |
Wyeth |
Combinations of SSRI and estrogenic agents
|
|
AR030064A1
(es)
*
|
2000-07-06 |
2003-08-13 |
Wyeth Corp |
Metodos para inhibir los efectos uterotroficos de los agentes estrogenicos
|
|
WO2002003988A2
(en)
*
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted indole compounds for treating neuropeptide y-related conditions
|
|
EP1296674A2
(en)
*
|
2000-07-06 |
2003-04-02 |
Wyeth |
Use of substituted indole compounds for increasing nitric oxide synthase activity
|
|
AU2001271706A1
(en)
*
|
2000-07-06 |
2002-01-21 |
American Home Products Corporation |
Use of substituted indole compounds for treating breast disorders
|
|
EP1177787A3
(en)
*
|
2000-07-28 |
2003-09-10 |
Pfizer Products Inc. |
Use of an estrogen agonist/antagonist for treating cataracts
|
|
EP1395563B1
(en)
|
2001-05-22 |
2006-03-29 |
Eli Lilly And Company |
2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
|
|
EP1401446B1
(en)
|
2001-05-22 |
2005-02-09 |
Eli Lilly And Company |
Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
|
|
RU2355397C2
(ru)
*
|
2002-06-13 |
2009-05-20 |
Уайт |
Режимы лечения базедоксифеном
|
|
PL374845A1
(en)
|
2002-07-22 |
2005-11-14 |
Eli Lilly And Company |
Selective estrogen receptor modulators containing a phenylsulfonyl group
|
|
CA2512000C
(en)
|
2002-12-26 |
2011-08-09 |
Eisai Co., Ltd. |
Selective estrogen receptor modulator
|
|
US7250440B2
(en)
*
|
2003-08-12 |
2007-07-31 |
Wyeth |
(Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents
|
|
TW200536845A
(en)
|
2004-04-07 |
2005-11-16 |
Wyeth Corp |
Crystalline polymorph of bazedoxifene acetate
|
|
RU2006132180A
(ru)
|
2004-04-07 |
2008-05-20 |
Вайет (Us) |
Кристаллический полиморф базедоксифен ацетата
|
|
BRPI0509385A
(pt)
|
2004-04-08 |
2007-09-18 |
Wyeth Corp |
composto, composição, métodos de preparar o sal, ea dispensão sólida, de tratar um mamìfero tendo uma doença ou sìndrome associadas com a deficiência de estrogênio ou excesso de estrogênio, uma doença ou distúrbio associados com a proliferação ou desenvolvimento anormal dos tecidos endometriais, de tratar cáncer de mama em um mamìfero, e uma mulher pós-menopáusica quanto a um ou mais distúrbios vasomotores, de reduzir colesterol, e de inibir perda óssea em um mamìfero, dispersão sólida, e, uso de um composto
|
|
US7772271B2
(en)
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
EA200700243A1
(ru)
|
2004-07-14 |
2007-08-31 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
Способы лечения гепатита с
|
|
US7868037B2
(en)
|
2004-07-14 |
2011-01-11 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
EP1781289A1
(en)
|
2004-07-22 |
2007-05-09 |
PTC Therapeutics, Inc. |
Thienopyridines for treating hepatitis c
|
|
WO2006017639A2
(en)
*
|
2004-08-05 |
2006-02-16 |
Wyeth |
Crystalline polymorph of pipindoxifene hydrochloride monohydrate
|
|
CN106038572A
(zh)
|
2004-10-20 |
2016-10-26 |
恩多研究公司 |
性甾体前体单独或与选择性雌激素受体调节剂联合用于预防和治疗绝经后女性的性功能障碍
|
|
FR2880625B1
(fr)
*
|
2005-01-07 |
2007-03-09 |
Sanofi Aventis Sa |
Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
|
US20100087661A1
(en)
*
|
2007-02-12 |
2010-04-08 |
Josef Jirman |
Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole
|
|
US8268806B2
(en)
|
2007-08-10 |
2012-09-18 |
Endorecherche, Inc. |
Pharmaceutical compositions
|
|
EP2252585B1
(en)
*
|
2008-02-11 |
2013-11-06 |
Wyeth LLC |
Methods of preparing polymorphic form a of bazedoxifene acetate
|
|
RS54165B1
(sr)
|
2008-04-16 |
2015-12-31 |
Karo Bio Ab |
Novi ligandi za estrogenski receptor
|
|
JP2012523445A
(ja)
*
|
2009-04-13 |
2012-10-04 |
サンド・アクチエンゲゼルシヤフト |
バゼドキシフェン酢酸塩およびその中間体を合成するための方法
|
|
US20100317635A1
(en)
|
2009-06-16 |
2010-12-16 |
Endorecherche, Inc. |
Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
|
|
ITMI20091109A1
(it)
*
|
2009-06-23 |
2010-12-24 |
Wyeth Corp |
Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione
|
|
SG186333A1
(en)
|
2010-06-16 |
2013-01-30 |
Endorech Inc |
Methods of treating or preventing estrogen-related diseases
|
|
US7968732B1
(en)
|
2010-09-07 |
2011-06-28 |
Divi's Laboratories, Ltd. |
Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole
|
|
US9212172B2
(en)
|
2010-09-14 |
2015-12-15 |
Dr. Reddy's Laboratories Limited |
Preparation of crystalline bazedoxifene and its salts
|
|
US8569483B2
(en)
|
2011-06-21 |
2013-10-29 |
Divi's Laboratories, Ltd. |
Process for the preparation of bazedoxifene acetate and intermediates thereof
|
|
CN102690225B
(zh)
*
|
2012-04-11 |
2014-12-24 |
南京友杰医药科技有限公司 |
巴多昔芬的合成方法
|
|
WO2014186325A1
(en)
*
|
2013-05-15 |
2014-11-20 |
Indiana University Research And Technology Corporation |
Processes and intermediates for preparing indole pharmaceuticals
|
|
US9744177B2
(en)
|
2014-03-10 |
2017-08-29 |
Endorecherche, Inc. |
Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
|
|
ES2939940T3
(es)
|
2014-03-28 |
2023-04-28 |
Univ Duke |
Tratamiento del cáncer de mama utilizando moduladores selectivos de los receptores de estrógenos
|
|
US9421264B2
(en)
|
2014-03-28 |
2016-08-23 |
Duke University |
Method of treating cancer using selective estrogen receptor modulators
|
|
WO2016097071A1
(en)
*
|
2014-12-18 |
2016-06-23 |
F. Hoffmann-La Roche Ag |
Estrogen receptor modulators and uses thereof
|
|
KR20190110400A
(ko)
|
2018-03-20 |
2019-09-30 |
엠에프씨 주식회사 |
새로운 중간체를 이용한 바제독시펜의 제조방법
|
|
IT201800006562A1
(it)
*
|
2018-06-21 |
2019-12-21 |
|
Procedimento e intermedi utili per la preparazione di indoli
|
|
IT201900001923A1
(it)
|
2019-02-11 |
2020-08-11 |
Erregierre Spa |
Sali di bazedoxifene utili per la preparazione di bazedoxifene acetato
|
|
US11246874B1
(en)
|
2021-04-20 |
2022-02-15 |
Oxygen Biotech LLC |
Treatment of COVID-19
|